Naurex, Inc, an affiliate of Allergan plc
Quick facts
Phase 3 pipeline
- Placebo-matching Rapastinel · Psychiatry/Neurology
Rapastinel is an NMDA receptor modulator that enhances glutamatergic neurotransmission by potentiating NMDA receptor function to improve cognitive and psychiatric symptoms.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Naurex, Inc, an affiliate of Allergan plc portfolio CI brief
- Naurex, Inc, an affiliate of Allergan plc pipeline updates RSS
Frequently asked questions about Naurex, Inc, an affiliate of Allergan plc
What is Naurex, Inc, an affiliate of Allergan plc's pipeline?
Naurex, Inc, an affiliate of Allergan plc has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Placebo-matching Rapastinel.
Related
- Sector hub: All tracked pharma companies